Table 2.
MCI subject profiles
| Age (years) | Sex | Brain Weight (g) | PMI (h) | Braak | |
|---|---|---|---|---|---|
| Control 1 | 93 | Female | 1080 | 2.75 | 2 |
| Control 2 | 74 | Male | 1140 | 4.00 | 1 |
| Control 3 | 86 | Female | 1150 | 1.75 | 1 |
| Control 4 | 76 | Female | 1315 | 2.00 | 1 |
| Control 5 | 79 | Male | 1240 | 1.75 | 2 |
| Control 6 | 86 | Female | 1300 | 3.75 | 1 |
| Average | 82 ± 7.2 | 1204 ± 95 | 2.67 ± 1.01 | 1.33 ± 0.52 | |
| MCI 1 | 99 | Female | 930 | 2.00 | 5 |
| MCI 2 | 88 | Female | 1080 | 2.25 | 5 |
| MCI 3 | 87 | Male | 1200 | 3.50 | 4 |
| MCI 4 | 87 | Male | 1170 | 2.25 | 3 |
| MCI 5 | 91 | Female | 1155 | 5.00 | 3 |
| MCI 6 | 82 | Female | 1075 | 3.00 | 3 |
| Average | 89 ± 5.7 | 1102 ± 98 | 3.0 ± 1.1 | 3.8 ± 1.0 |
PMI = post mortem interval
Braak = indicates severity of AD pathology (based on the number of senile plaques and neurofibrillary tangles in the brain.) The scale ranges from 1 to 6.